WilliamTyorMD

PubMed

• Honokiol hexafluoro confers reversal of neuropathological markers of HIV infection in a murine SCID model.
  Zhan Zhang, Aaron Scanlan, Rajeth Koneru, Chelsea Richardson Morrell, Monica D Reece, Emily Edwards, Sebastian Roa, Christina Gavegnano, Heather Bimonte-Nelson, Jack A...> ;Neurotherapeutics. 2024 Mar 1
• 2 citations
  Exploration of potential immune mechanisms in cervical dystonia.
  Laura M Scorr, Gamze Kilic-Berkmen, Diane J Sutcliffe, Ashok R Dinasarapu, J Lucas McKay, Pritha Bagchi, Michael D Powell, Jeremy M Boss, Nezih Cereb, Marian Little, L...> ;Parkinsonism & Related Disorders. 2024 Feb 17
• 2 citations
  A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment.
  Aaron Scanlan, Zhan Zhang, Rajeth Koneru, Monica Reece, Christina Gavegnano, William Tyor, Albert M Anderson> ;Microorganisms. 2022 Nov 12
• 4 citations
  Neurological Complications in Children Hospitalized With Seizures and Respiratory Infections: A Comparison Between SARS-CoV-2 and Other Respiratory Infections.
  Grace Gombolay, Monique Anderson, Yijin Xiang, Shasha Bai, Christina A Rostad, William Tyor> ;Pediatric Neurology. 2022 Oct 1
• 14 citations
  Immune responses to SARS-CoV-2 vaccination in multiple sclerosis: a systematic review/meta-analysis.
  Grace Y Gombolay, Monideep Dutt, William Tyor> ;Annals of Clinical and Translational Neurology. 2022 Aug 1
• 2 citations
  Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model.
  Christina Gavegnano, Woldeab B. Haile, Raj Koneru, Selwyn J. Hurwitz, James J. Kohler, William R. Tyor, Raymond F. Schinazi> ;Journal of Neurovirology. 2020 Sep 8
• 3 citations
  HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension.
  Sharilyn Almodovar, Brandy E. Wade, Kristi M. Porter, Justin M. Smith, Robert Alexis Lopez-Astacio, Kaiser M. Bijli, Bum-Yong Kang, Sushma K. Cribbs, David M. Guidot, ...> ;Scientific Reports. 2020 Jul 16
• 39 citations
  Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
  Christina Fournier, Richard Bedlack, Colin Quinn, James A. Russell, Diane Beckwith, Kathleen H Kaminski, William R. Tyor, Vicki S. Hertzberg, Virginia James, Meraida P...> ;JAMA Neurology. 2020 Apr 1
• 27 citations
  CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease.
  Jacqueline F Rosenthal, Benjamin M Hoffman, William R. Tyor> ;Journal of Investigative Medicine. 2020 Feb 1
• 31 citations
  Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro
  Christina Gavegnano, Woldeab B. Haile, Selwyn J. Hurwitz, Sijia Tao, Yong Jiang, Raymond F. Schinazi, William R. Tyor> ;Journal of Neuroinflammation. 2019 Sep 27
• 14 citations
  Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder
  Tugba Ozturk, J. Christina Howell, David W. Loring, Drenna Waldrop-Valverde, Donald Franklin, Scott Letendre, William R. Tyor, William T. Hu, Alexander L. Kollhoff, Al...> ;Scientific Reports. 2019 Jun 19
• 85 citations
  CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
  William T. Hu, Jennifer C. Howell, Tugba Ozturk, Umesh Gangishetti, Jaime M. Hatcher-Martin, William R. Tyor, Alexander L. Kollhoff, Albert M. Anderson> ;Frontiers in Immunology. 2019 Mar 15
• 34 citations
  Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders
  Jacqueline F Rosenthal, William R. Tyor> ;Journal of Neurovirology. 2019 Mar 13
• 12 citations
  Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorder mouse model.
  Rajeth Koneru, Heather A. Bimonte-Nelson, Vincent T. Ciavatta, Woldeab B. Haile, Kate Elmore, Jennifer Ward, Leonard Maroun, William R. Tyor> ;AIDS. 2018 Jul 17
• 10 citations
  A mouse model of HIV-associated neurocognitive disorders: a brain-behavior approach to discover disease mechanisms and novel treatments
  William R. Tyor, Heather A. Bimonte-Nelson> ;Journal of Neurovirology. 2018 Apr 1
• 5 citations
  Measurement of Human Immunodeficiency Virus p24 Antigen in Human Cerebrospinal Fluid With Digital Enzyme-Linked Immunosorbent Assay and Association With Decreased Neur...
  William R. Tyor, Mark J. Mulligan, Drenna Waldrop-Valverde, Jeffrey L. Lennox, Scott Letendre, Albert M. Anderson> ;Clinical Infectious Diseases. 2018 Jun 18
• 21 citations
  In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals.
  Vincent T. Ciavatta, Edyta K. Bichler, Iris Speigel, Courtney C. Elder, Shavonne L Teng, William R. Tyor, Paul S. García> ;Neurochemical Research. 2017 Aug 2
• 92 citations
  Update on disease-modifying therapies for multiple sclerosis.
  Diana L Vargas, William R. Tyor> ;Journal of Investigative Medicine. 2017 Jun 1
• 19 citations
  Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa
  Brahmchetna Bedi, Nicholas M. Maurice, Vincent T. Ciavatta, K. Sabrina Lynn, Zhihong Yuan, Samuel A. Molina, Myungsoo Joo, William R. Tyor, Joanna B. Goldberg, Michael...> ;FASEB Journal. 2017 Apr 25
• HIV latency reversal research and the potential effects on the central nervous system: is concern warranted?
  Raymond F. Schinazi, William R. Tyor, Albert M. Anderson> ;Journal of the International AIDS Society. 2016 Sep 5
• 23 citations
  Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
  Jeffrey L. Lennox, Mark M. Mulligan, David W. Loring, Henrik Zetterberg, Kaj Blennow, Cari F. Kessing, Rajeth Koneru, Kirk A. Easley, William R. Tyor, Albert M. Anderson> ;Journal of Neurovirology. 2017 Feb 1
• 7 citations
  Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
  Jeffrey L. Lennox, Minh Ly Nguyen, Drenna Waldrop-Valverde, William R. Tyor, David W. Loring, Albert M. Anderson> ;Journal of Neurovirology. 2016 May 31
• 51 citations
  The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model.
  Woldeab B. Haile, Christina Gavegnano, Sijia Tao, Yong Jiang, Raymond F. Schinazi, William R. Tyor> ;Neurobiology of Disease. 2016 Aug 1
• 15 citations
  Concentration-Dependent Dual Role of Thrombin in Protection of Cultured Rat Cortical Neurons
  Paul S. García, Vincent T. Ciavatta, Jonathan A. Fidler, Anna Woodbury, Jerrold H. Levy, William R. Tyor> ;Neurochemical Research. 2015 Sep 5
• 32 citations
  HIV-associated neurocognitive disorders: Five new things
  Jeffrey Rumbaugh, William R. Tyor> ;Neurology. Clinical Practice. 2015 Jun 1
• Join now to see all

Journal Articles

• The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model  
  Fritz-French C, Shawahna R, Ward JE, Maroun LE, Tyor WR, J Interferon and Cytokine Res, 1/1/2014
• Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause in...  
  Rao Vasudev R, Ujjwal Neogi, Joshua S Talboom, Ligia Padilla, Mustafizur Rahman, Cari Fritz-French, Sandra Gonzalez-Ramirez, Anjali Verma, Charles Wood, Ruth M Ruprech..., Retrovirology, 1/1/2013
• Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders  
  Tyor WR, Fritz-French C, Nath A, J Neurovirol, 1/1/2013
• Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model  
  Koneru R, Olive MF, Tyor WR, J Neurovirol, 1/1/2013
• Morphine Exposure During HIV Encephalitis in SCID Mice  
  Tyor WR, Hwang HE, Fritz-French C, Neurochem Res, 1/1/2012
• Interferon-alpha neurotoxicity  
  Fritz-French C, Tyor WR, Cytokine and Growth Factor Rev, 1/1/2012
• Regulation of Th1/Th17 cytokine and IDO gene expression by inhibition of calpain in PBMCs from MS patients  
  Smith AW, Doonan BP, Tyor WR, Abou-Fayssal N, Haque A, Banik NL, J Neuroimmunol, 1/1/2011
• Interferon Alpha Causes Neuronal Dysfunction in Encephalitis  
  Sas A, Bimonte-Nelson H, Smothers CT, Woodward J, Tyor W, J Neurosci, 1/1/2009
• Reduced leukocyte chemotaxis and chemokine induction by a subtype C HIV isolate in vitro correlates with reduction in neuropathology and cognitive dysfunction in SCID ...  
  Rao V, Sas A, Eugenin E, Siddappa N, Bimonte-Nelson H, Berman J, Ranga U, Tyor WR, Prasad VR, J Neurosci, 1/1/2008
• Increased Calpain Correlates with Th1 Cytokine Profile from MS Patients  
  Imam S, Guyton MK, Haque A, Vandenbark A, Tyor WR, Ray SK, Banik NL, J. Neuroimmunol, 1/1/2007
• Chronic cocaine exposure in a SCID mouse model of HIV encephalitis  
  Griffin WC, Middaugh LD, Tyor WR, Brain Research, 1/1/2007
• The pathogenesis of HIV-associated dementia: Recent advances using a SCID mouse model of HIV encephalitis  
  Cook J, Tyor WR, Einstein J Biol Med, 1/1/2006
• Impact of Opiate-HIV-1 interactions on neuronal signaling  
  Hauser KF, El-Hage N, Buch S, Nath A, Tyor WR, Bruce-Keller AJ, Knapp PE, J Neuroimmune Pharm, 1/1/2006
• Commentary: Infections and MS  
  Tyor W, International J MS Care, 1/1/2006
• The use of statins in multiple sclerosis  
  Tyor WR, Inderjit Singh, Timothy Vollmer, Lyndon Key, John Corboy, Silva Markovic-Plese, Jana Preningerova, Valerie Durkalski, Marco Rizzo, International J Multiple Sclerosis Care, 1/1/2006
• Highly active antiretroviral therapy of HIV-encephalitis in immunodeficient mice  
  Cook J, Dasgupta S, Terry E, Gorry P, Wesselingh S, Middaugh L, and Tyor W, Ann Neuro, 1/1/2005
• Upregulation of Calpain Correlated with Increased Neurodegeneration in Acute Experimental Allergic Encephalomyelitis  
  Guyton M.K., Wingrave J.M., Yallapragada A.V., Wilford Gloria G., Sribnick Eric A., Matzelle D.D., Tyor W.R., Ray Swapan K., Banik Naren, J Neurosci Res, 1/1/2005
• Molecular targets of opiate drug abuse in NeuroAIDS  
  Hauser KF, El-Hage N, Berger JR, Tyor WR, Nath A, Bruce-Keller AJ, Knapp PE, Neurotoxicity Res, 1/1/2005
• The SCID mouse model of HIV encephalitis: Deficits in cognitive function  
  Griffin WC, Cook JE, Middaugh L, Tyor WR, J NeuroVirol, 1/1/2004
• Treatment of spinal cord injury in the rat with Transforming Growth Factor-beta 1  
  Tyor WR, Avgeropoulos N, Ohlandt G, Hogan EL, J Neurol Sci, 1/1/2002
• A randomized, comparative study of interferon beta dose in MS: the EVIDENCE trial  
  H Panitch, MD, D Goodin, MD, PK Coyle, MD, P O'Connor, MD, B Weinshenker, MD, for the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparati..., Neurology, 1/1/2002
• Recombinant interferon-alpha-induced chorea and frontal sub-cortical dementia (Letter to the Editor)  
  Zhang R, Tyor WR, Neurology, 1/1/2002
• Acute multiple sclerosis characterized by extensive mononuclear phagocyte infiltration  
  Shields DC, Avgeropoulos NG, Banik NL, Tyor WR, Neurochem Research, 1/1/2000
• Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis  
  Jacobs LD, Beck RW, Simon JH, et.al., N. Eng. J. Med., 1/1/2000
• Do drugs of abuse alter the onset and course of HIV-associated dementia complex?  
  Tyor WR, Middaugh LD, J Leukocyte Biol, 1/1/1999
• Join now to see all

Books/Book Chapters

• Handbook of Clinical Neurology 
  Chapter: Mumps and Rubella. 
  Page 591 - 600Tyor W, Harrison TEditors: Tselis A and Booss J.Elsevier2013
• Viral Infections of the Human Nervous System 
  Chapter: T. Human Immunodeficiency Virus Infection/AIDS. 
  Page 145 - 181Rumbaugh J, Harrison T, Tyor WREditors: Jackson A.Springer Basel2012
• Handbook of Neurochemistry and Molecular Neurobiology 
  Chapter: Pathogenesis and treatment of HIV-associated dementia: Recent studies in a SCID mouse model. 
  Page 471 - 489Tyor WREditors: Banik N.Springer-Verlag Berlin Heidelberg2009
• NORD Guide to Rare Disorders 
  Chapter: Selected Encephalitides. 
  Page 284 - 285Kaliszky Z, Tyor WRLippincott Williams & Wilkins, Philadelphia, PA2003
• Drug Therapy Pocket 
  Chapter: Neurology. 
  Carter T, Kaliszky Z, Pritchard P, Tyor W and Walker AEditors: Philipp Boerm, M.D..Borm Bruckmeier Publishing LLC, Hermosa Beach, CA2003
• Expert Rev Neurotherapeutics 
  Chapter: Therapeutic Options in Neurosarcoidosis. 
  Kaliszky Z, Walker A, Tyor WR2002
• Current Treatment Options in Neurology 
  Chapter: Neurosarcoidosis. 
  Walker A, Tyor W2001
• Current Opinion in Neurology 
  Chapter: Update on Viral Encephalitis. 
  Page 369 - 374Hinson V, Tyor WREditors: Frackowiak R, editor; Young A, deputy editor, Irani D, section editor.Lippincott, Williams & Wilkins2001
• Practical Neuro-immunology 
  Chapter: Fundamentals of Immunology. 
  Page 3 - 33Tyor WREditors: Rolak LA, Harati Y.Butterworth Heinemann1997
• Neurological and Neuropsychiatric 
  Chapter: Nontransgenic Murine Animal Model Systems for the HIV-associated Cognitive Motor Complex. 
  Page 168 - 178Persidsky Y, Tyor WREditors: Gendelman HE, Lipton S, Epstein L, Swindells S.Chapman & Hall Publishers1997
• Office Practice of Neurology 
  Chapter: Acute disseminated encephalomyelitis. 
  Page 357 - 359Tyor WREditors: Samuels MH, Feske S, Mesalamm, Pessin MS, Preston DC, Rolak LA, Spierings ELH, Sudarsky LR, Wen P.Churchill-Livingstone, Inc.1996
• Cytokines and the CNS: Development, Defense and Disease 
  Chapter: Cytokines and Disease: HIV-Associated Dementia. 
  Page 287 - 307Wesselingh SL, Tyor WR, Griffin DEEditors: Benveniste T, Ransohoff R.CRC Press1996
• HIV, AIDS and the Brain 
  Chapter: Cytokine expression and pathogenesis in AIDS brain. 
  Page 203 - 222Vitkovic L, da Cunha A, Tyor WREditors: Price RW, Berry SW.Raven Press1994
• Current Therapy in Neurological Diseases 
  Chapter: Post-infectious encephalomyelitis and transverse myelitis. 
  Page 155 - 157Tyor WREditors: Johnson RT, Griffin JW.Mosby-Yearbook Publishers1993
• Neurotropic Viruses and Immunity 
  Chapter: Immune Responses and the Central Nervous System. 
  Page 15 - 39Tyor WR, Johnson RTEditors: Spector S, Bendinelli M, Friedman H.Plenum Publishing1992
• Join now to see all

Abstracts/Posters

• A Novel Interferon-alpha Inhibitor Reduces Histopathological Complications in a Mouse Model of HIV Encephalitis.
  Fritz-French C, Shawahna R, Ward JE, Maroun LE, Tyor WR, The 5th FIP Pharmaceutical Sciences World Congress, Melbourne, Australia, 1/1/2014
• The Effects of a Novel Interferon Inhibitor in a Model of HIV Encephalitis.
  Tyor WR, Kessing C, Shawahna R, Ward JE, Maroun LE, American Academy of Neurology Meeting, Philadelphia, PA, 1/1/2014
• MRI and CSF Analysis of Cognitive Impairment in Multiple Sclerosis.
  Ganesh G, Tyor W, Saindane A, Wandler E, Lava N, Drane D, Hu W, Consortium of MS Centers Meeting, Dallas, TX, 1/1/2014
• CSF Interferon Alpha Levels Inversely Correlate with Processing and Motor Speed in HIV-infected Subjects with Cognitive Complaints with and without HAND.
  Anderson AM, Loring DW, Lennox JL, Patel N, Fritz-French C, Sethi N, Rosen J, Koneru R, and Tyor WR, Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 1/1/2013
• HIV associated dementia as a surrogate human model for Down Syndrome Cognitive difficulties.
  Maroun LE, Jagadeesh A, Gutman LB, Ward JE, Tyor WR, Conference on Cognition in Down Syndrome, Washington, DC, 1/1/2013
• Clade C HIV-1 isolates from Southern Africa bear a unique genetic signature in Tat and display a higher frequency of dicysteine motif containing variants that cause in...
  Rao VR, Neogi U, Talboom J, Padilla L, Rahman M, Eugenin E, Fritz-French C, Gonzalez S, Prasadarao N, Wood C, Ruprecht R, Ranga U, Azim T, Joska J, Shet A, Bimonte-Nel..., Cold Spring Harbor, 1/1/2013
• Interferon-alpha is toxic to neurons in vitro.
  Fritz-French C, Zhang L, Bassell G, Tyor WR, American Association of Immunologists Annual Meeting, Honolulu, HI, 1/1/2013
• Interferon-alpha is toxic to neurons in vitro.
  Fritz-French C, Zhang L, Bassell G, Tyor WR, International Society for Neurovirology Meeting, Washington, DC, 1/1/2013
• HIV-1 gp120 and Tat are determinants of intra-clade, regional differences in the neurovirulence of Clade C isolates.
  Rao VR, Neogi U, Talboom J, Eugenin E, Prasadarao N, Bimonte-Nelson H, Tyor W, Prasad VR, International Society for Neurovirology Meeting, Washington, DC, 1/1/2013
• In vitro Studies of Interferon-alpha Neurotoxicity.
  William Tyor, Cari Fritz-French, Kristy Welshhans, Lynn Zhang, Andrew Sas, Gary Bassell, American Academy of Neurology Meeting, New Orleans, LA, 1/1/2012
• In vitro Studies of Interferon-alpha Neurotoxicity.
  Fritz-French C, Zhang L, Bassell G, Tyor WR, American Association of Immunologists, Boston, MA, 1/1/2012
• SCID Mice with HIV Encephalitis Treated with B18, a Novel Interferon-alpha Blocker.
  W Tyor, Hee Young Hwang, Cari Fritz-French, Jennifer Ward, Leonard Maroun, American Academy of Neurology Meeting, Honolulu, HI, 1/1/2011
• HIV-1 Tat Increases Hydrogen Peroxide and 5-Lipoxygenase in Pulmonary Artery Endothelial Cells.
  K.M. Porter, Cari Fritz-French, William Tyor, and Roy L. Sutliff, Experimental Biology Research Conference, Washington, DC, 1/1/2011
• Mechanisms underlying clade-specific differences in HIV associated neuropathogenesis.
  Vasudev R. Rao, Ligia Padilla, Cari Fritz-French Heather Bimonte-Nelson, William R. Tyor and Vinayaka R. Prasad, Cold Spring Harbor Laboratory Meeting on Retroviruses, Cold Spring Harbor, NY, 1/1/2011
• An Optimal Thrombin Concentration Preserves Dendritic Branching in Cortical Neuron Cultures.
  Woodbury A, Maddi M, Fidler J, Fritz-French C, Tyor WR, Garcia PS, American Society of Anesthesiologists Annual Meeting, Washington, DC, 1/1/2011
• Treatment of mice with HIV encephalitis with a novel interferon-alpha blocker.
  Tyor WR, Fritz-French C, Hwang HY, Padilla L, Koneru R, Ward, J, Dettenhofer M, Maroun L, American Academy of Neurology Meeting, Toronto, Canada, 1/1/2010
• Treatment of mice with HIV encephalitis with a novel interferon-alpha blocker.
  Tyor WR, Fritz-French C, Hwang HY, Padilla L, Koneru R, Ward, J, Dettenhofer M, Maroun L, American Neurological Association Meeting, San Francisco, CA, 1/1/2010
• Opiate interactions in SCID mice with HIV encephalitis.
  WR Tyor, Sas A , Jones R, Xu R, Knapp P, Hauser K, American Academy of Neurology, Seattle, WA, 1/1/2009
• Cerebellar dysfunction is associated with neurocognitive impairment in multiple sclerosis patients.
  Lee-Wilk T, Royal W, Wallin M, Finklestein J, Bever C, Maloni H, McCarthy M, Tyor W, Levin M, Hershey L, Kane R, Consortium of MS Centers Meeting, Atlanta, GA, 1/1/2009
• Concurrent diagnosis of multiple sclerosis and HIV infection in US military veterans.
  Vargas DL, Culpepper J, Berger J, McCarthy M, Tyor W, Levin M, Bever C, Royal W, American Neurological Association Meeting, Baltimore, MD, 1/1/2009
• Cerebellar dysfunction and neurocognitive impairment in multiple sclerosis.
  Lee-Wilk T, Kane R, Wallin M, Finkelstein J, Bever C, Maloni H, McCarthy M, Tyor W, Levin M, Hershey L, Royal W, American Neurological Association Meeting, Baltimore, MD, 1/1/2009
• Neutralizing antibody treatment against interferon-alpha in SCID mice with HIV encephalitis and interferon-alpha neurotoxicity.
  Tyor WR, Bimonte-Nelson H, Smothers C, Woodward J, Sas A, American Academy of Neurology, Chicago, IL, 1/1/2008
• CD454RA+ T Helper Cell Percentages Correlate with Measures Related to Cognitive Function in Patients with Multiple Sclerosis (MS).
  Royal W, Wallin M, Kane R, Maloni HW, Culpeper WJ, McCarthy M, Tyor WR, Mia Y, Ford D, Bever C, American Academy of Neurology, Chicago, IL, 1/1/2008
• Morphine interactions with HIV encephalitis in SCID mice.
  WR Tyor, Jones R, Hauser K, Sas A, American Neurological Association, Salt Lake City, UT, 1/1/2008
• Clinical Characteristics of African Americans with MS: The VA Longitudinal MS Study.
  Mitchell Wallin, William Culpepper, Walter Royal, Robert Kane, Douglas Bradham, Heidi Maloni, Margaret Koehler, William Tyor, Micheline McCarthy, Jeffrey Harrow, Peggy..., ACTRIMS, Washington, DC, 1/1/2007
• Join now to see all

Lectures

• Invited Speaker: "Brief overview of MS and studies at the Emory/Atlanta VAMC MS Center." 
  1/1/2014
• Invited Speaker: "HIV Associated Neurocognitive Disorders." 
  University of Florida School of Medicine, Department of Neurology - 1/1/2014
• Visiting Professor/Grand Rounds: "HIV associated neurocognitive disorders." 
  North Shore LIJ Health System, Department of Neurology, Great Neck, NY - 1/1/2012
• Invited Speaker: "New and emerging immunotherapies for multiple sclerosis: oral agents." 
  Las Vegas, NV - 1/1/2012
• Invited Speaker: "Relapsing remitting MS: Focus on newer agents." 
  Las Vegas, NV - 1/1/2012
• Invited Speaker: "Treating Multiple Sclerosis: What are the current and future therapies?" 
  Charleston, SC - 1/1/2011
• Invited Speaker: "MS treatment issues: Relapsing disease-Interferons and glatiramer acetate." 
  Orlando, FL - 1/1/2011
• Invited Speaker: "Safety Issue When Using Monoclonal Antibodies and Emerging Therapies in MS." 
  Atlanta, GA - 1/1/2010
• Invited Speaker: "Taking Care of MS Patients" 
  Charleston, SC - 1/1/2010
• Invited Speaker: "Update on MS Disease Modifying Therapies." 
  Charleston, SC - 1/1/2010
• Invited Speaker: "Cladribine." 
  Baltimore, MD - 1/1/2010
• Invited Speaker: "Current and future treatment of multiple sclerosis." 
  Atlanta, GA - 1/1/2010
• Visiting Professor/Grand Rounds: "The potential role of interferon-alpha in HIV associated neurocognitive disorders." 
  Johns Hopkins University School of Medicine Department of Neurology, Baltimore, MD - 1/1/2010
• Invited Speaker: "Multiple Sclerosis Research." 
  Destin, FL - 1/1/2009
• Invited Speaker: "Cocaine administration in SCID mice with HIV encephalitis." 
  Charlotte, SC - 1/1/2008
• Invited Speaker: "MS Models of Care." 
  Baltimore, MD - 1/1/2008
• Visiting Professor: "Interferon-alpha: A potentially treatable cause of cognitive dysfunction in HIV-associated dementia." 
  Emory University School of Medicine Department of Neurology - 1/26/2007
• Invited Speaker: "Immunomodulating monoclonal antibodies should be used in MS patients: Con." 
  Baltimore, MD - 1/10/2007
• Invited Speaker: "Advances in MS Research: Tysabri and Beyond." 
  Atlanta, GA - 1/7/2007
• Invited Speaker: "Fatigue and MS." 
  Charlotte, NC - 1/1/2007
• Invited Speaker: "Fatigue and MS" 
  Charlotte, NC - 1/28/2006
• Invited Speaker: "Newest potential treatments for MS." 
  Charlotte, NC - 1/28/2006
• Invited Speaker: "Clade B and C infections in the SCID mouse model of NeuroAIDS." 
  Curitiba, Brazil - 1/21/2006
• Invited Speaker: "MS associated viruses: Who's next ?" 
  Baltimore, MD - 1/18/2006
• Invited Speaker: "Multiple Sclerosis: Advanced therapies." 
  Orangeburg Regional Medical Center - 1/17/2005
• Join now to see all

Other

• Degenerative Brain Diseases Caused by "Slow" Viruses and UnConventional Agents (PRIONS). 
  Goust JM, Tyor WR, "Infection and Immunity" Course Syllabus (Gabriel Virella. M.D., Ph.D., editor)
  Medical University of South Carolina, Charleston - 1/1/2003